Viewing StudyNCT03470311



Ignite Creation Date: 2024-05-06 @ 11:16 AM
Last Modification Date: 2024-10-26 @ 12:42 PM
Study NCT ID: NCT03470311
Status: COMPLETED
Last Update Posted: 2023-01-20
First Post: 2018-03-01

Brief Title: Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
Sponsor: McMaster University
Organization: McMaster University

Organization Data

Organization: McMaster University
Class: OTHER
Study ID: 17-12992
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: McMaster University
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
AstraZeneca INDUSTRY
St Josephs Healthcare Hamilton OTHER